Screening, identification, and management of prediabetes to reduce cardiovascular risk: A missed opportunity?

Diabetes Metab Res Rev. 2020 Sep;36(6):e3316. doi: 10.1002/dmrr.3316. Epub 2020 Apr 15.

Authors

Dave L Dixon¹, Salvatore Carbone²

Affiliations

¹ Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.
² Department of Kinesiology & Health Sciences, Virginia Commonwealth University, Richmond, Virginia, USA.

PMID: 32223033
DOI: 10.1002/dmrr.3316

No abstract available

MeSH terms

Cardiovascular Diseases / etiology
Cardiovascular Diseases / pathology
Cardiovascular Diseases / prevention & control*
Diabetes Mellitus / diagnosis
Diabetes Mellitus / drug therapy*
Diabetes Mellitus / physiopathology
Disease Management
Heart Disease Risk Factors
Humans
Mass Screening / standards*
Prediabetic State / complications
Prediabetic State / diagnosis
Prediabetic State / drug therapy*
Prognosis